Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sy3dney sy3dney Jul 19, 2006 12:56 PM Flag

    Re: Analysts

    Larry -

    Remember in the mid-90s when we didn't have any coverage except for 1 biotech news letter?

    We've been here, done that!

    IMO, at this price, the greatest return now will come to the investor, not the trader. IMGN is LONG overdue for a few things to go right for a change.

    With the increased knowledge of how our bodies actually work, and the combined efforts of our partners, I really think things will get better than the price reflects down here. Analysts will "initiate" coverage once again as good things pan out -- the same ones that at one point recommended us, and that have been following us for years by covering our partners.

    Just my personal viewpoint --

    Jon

 
IMGN
7.12-0.52(-6.81%)Feb 8 4:00 PMEST